Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123164) titled 'Application of GPC3-targeting Fluorescent Probe in Specific Fluorescence Staining and Intraoperative Localization of Hepatocellular Carcinoma' on April 22.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Zhongshan Hospital, Fudan University
Condition:
Hepatocellular Carcinoma
Intervention:
Regular dose group:GPC3-03-ICG fluorescent probe, 1.5 mg/kg, single peripheral intravenous administration
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-05-01
Target Sample Size: Regular dose group:10;Low dose group:10;
Countries of Recruitment:
China
To kn...